tiprankstipranks
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Prime Medicine, Inc. (PRME) Similar Stocks

Compare
594 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prime Medicine, Inc.
$3.13
$392.17M
-62.96%
2 Buy
0 Hold
0 Sell
Moderate Buy
Editas Medicine
$2.06
$170.05M
-74.02%
4 Buy
9 Hold
2 Sell
Hold
Intellia Therapeutics
$12.25
$1.17B
-54.43%
11 Buy
2 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$50.43
$4.48B
-41.49%
12 Buy
8 Hold
1 Sell
Moderate Buy
Beam Therapeutics
$33.14
$2.77B
4.35%
11 Buy
2 Hold
0 Sell
Strong Buy
Verve Therapeutics
$7.83
$718.37M
-40.37%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
PRME
Prime Medicine, Inc.
3.13
-5.32
-62.96%
EDIT
Editas Medicine
2.06
-5.87
-74.02%
NTLA
Intellia Therapeutics
12.25
-14.93
-54.93%
CRSP
Crispr Therapeutics AG
50.43
-35.76
-41.49%
BEAM
Beam Therapeutics
33.14
-0.40
-1.19%
VERV
Verve Therapeutics
7.83
-5.49
-41.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis